Medisum Biotech Private Limited

Product Name: VILDAMED 50
Salt Composition: Vildagliptin Tablets IP 50 mg

Description:
VILDAMED 50 contains Vildagliptin, an oral antidiabetic agent belonging to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors. It is used as part of a comprehensive management plan for Type 2 Diabetes Mellitus to help control blood glucose levels, either as monotherapy or in combination with other antidiabetic medications like metformin, sulfonylureas, or insulin.

Tenesure 20 Tablet – Teneligliptin 20 mg | DPP-4 Inhibitor for Type 2 Diabetes

Description:

Tenesure 20 contains Teneligliptin 20 mg, a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of Type 2 Diabetes Mellitus. It helps improve glycemic control by increasing insulin secretion and decreasing glucagon levels in a glucose-dependent manner. Tenesure 20 is typically prescribed when diet and exercise alone do not provide adequate blood sugar control, and it can be used alone or in combination with other antidiabetic medications.

Mechanism of Action:
Teneligliptin works by inhibiting the DPP-4 enzyme, which prolongs the action of incretin hormones. This leads to increased insulin release and decreased glucose production, helping to reduce both fasting and postprandial blood glucose levels.

TENESURE M 500 is a fixed-dose combination of Teneligliptin and Metformin Hydrochloride (Extended Release), formulated to provide effective glycemic management in patients with type 2 diabetes mellitus. This dual-action therapy combines the glucose-lowering benefits of a DPP-4 inhibitor with the extended-release formulation of Metformin, offering convenience, improved tolerability, and consistent glycemic control.
Key Features:

• Dual Mechanism of Action: Supports blood sugar regulation through complementary pathways.

• Extended-Release Metformin: Reduces gastrointestinal discomfort and ensures sustained effect.

• Convenient Dosing: Designed for once-daily administration under physician guidance.

• High-Quality Packaging: Alu-Alu blister to maintain stability and integrity of tablets.

Indication:For use as prescribed in the management of type 2 diabetes mellitus in adults requiring combination therapy for improved glycemic control.
Storage: Store in a cool, dry place, protected from light and moisture. Keep out of reach of children.

TENESURE M 1000 is a fixed-dose combination of Teneligliptin and Metformin Hydrochloride (Extended Release), designed to provide effective glycemic control in patients with type 2 diabetes mellitus. This combination therapy harnesses the complementary mechanisms of a DPP-4 inhibitor and extended-release Metformin to help manage blood glucose levels more efficiently, while reducing gastrointestinal side effects commonly associated with Metformin.
Key Features:
Dual Mechanism of Action: Combines Teneligliptin’s DPP-4 inhibition with Metformin’s glucose-lowering effect.
Extended-Release Metformin 1000 mg: Ensures gradual absorption for sustained efficacy and improved tolerability.
Convenient Dosing: Optimized for once-daily administration under physician guidance.
Premium Packaging: Alu-Alu blister to protect tablet stability and integrity.
Indication:Indicated for adult patients with type 2 diabetes mellitus requiring combination therapy for better glycemic control.
Storage: Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.